Tower Research Capital LLC (TRC) - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2016$31,000
+3.3%
82,880
-7.3%
0.00%0.0%
Q2 2016$30,000
+114.3%
89,386
+690.1%
0.00%
+50.0%
Q4 2015$14,000
+75.0%
11,313
+169.7%
0.00%
+100.0%
Q2 2015$8,000
-92.2%
4,194
-92.6%
0.00%
-92.3%
Q1 2015$103,00056,6190.01%
Q4 2014$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q3 2014$54,000
+217.6%
22,269
+252.6%
0.01%
+200.0%
Q2 2014$17,0006,3160.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,425,000$3,363,0002.66%
ACUTA CAPITAL PARTNERS, LLC 1,228,111$2,898,0001.96%
Sio Capital Management, LLC 505,000$1,192,0000.94%
RA Capital Management 2,500,000$5,900,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 750,000$1,770,0000.30%
TFS CAPITAL LLC 1,295,744$3,058,0000.29%
EAGLE ASSET MANAGEMENT INC 12,713,051$30,002,0000.17%
JW Asset Management, LLC 52,271$123,0000.09%
Lombard Odier Asset Management (USA) Corp 501,444$1,183,0000.08%
First Heartland Consultants, Inc. 74,624$176,0000.07%
View complete list of CTI BIOPHARMA CORP shareholders